Thinking “Green” When Treating “Pink Puffers” and “Blue Bloaters”—Reducing Carbon Footprint When Prescribing Inhalers

References

1. 1.↵
   1. Rossati A

   . Global Warming and Its Health Impact. Int J Occup Environ Med 2017;8:7–20.

   OpenUrlCrossRefPubMed
2. 2.↵
   1. Eckelman MJ,
   2. Sherman J

   . Environmental Impacts of the U.S. Health Care System and Effects on Public Health. Ahmad S, ed. PLOS ONE 2016;11:e0157014.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Pichler PP,
   2. Jaccard IS,
   3. Weisz U,
   4. Weisz H

   . International comparison of health care carbon footprints. Environ Res Lett 2019;14:064004064004.

   OpenUrlCrossRef
4. 4.↵
   1. Belkhir L,
   2. Elmeligi A

   . Carbon footprint of the global pharmaceutical industry and relative impact of its major players. J Clean Prod 2019;214:185–94.

   OpenUrlCrossRef
5. 5.↵
   1. Richie C

   . Environmental sustainability and the carbon emissions of pharmaceuticals. J Med Ethics 2021;medethics-2020-106842. April 14.
6. 6.↵
   1. Richie C

   . Can United States Healthcare Become Environmentally Sustainable? Towards Green Healthcare Reform. J Law Med Ethics 2020;48:643–52.

   OpenUrlPubMed
7. 7.↵
   1. Pritchard JN

   . The climate is changing for metered-dose inhalers and action is needed. Drug Des Devel Ther 2020;14:3043–55.

   OpenUrl
8. 8.↵
   About Montreal Protocol. Accessed August 9, 2022. Available from: https://www.unep.org/ozonaction/who-we-are/about-montreal-protocol.
9. 9.↵
   1. Janson C,
   2. Henderson R,
   3. Löfdahl M,
   4. Hedberg M,
   5. Sharma R,
   6. Wilkinson AJ

   . Carbon footprint impact of the choice of inhalers for asthma and COPD. Thorax 2020;75:82–4.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Stocker T

    . Climate Change 2013: The Physical Science Basis: Working Group I Contribution to the Fifth Assessment Report of the Intergovernmental Panel on Climate Change. Cambridge University press; 2014.
11. 11.↵
    1. Schmiemann G,
    2. Dörks M

    Klimabewusste Verordnung von inhalativen Arzneimitteln: DEGAM S1-Handlungsempfehlung: AWMF-Register-Nr. 053-059 Schmiemann G, Dörks M. Deutsche Gesellschaft für Allgemeinmedizin und Familienmedizin e.V., ed. Published online March 2022. Available from: https://www.degam.de/files/Inhalte/Leitlinien-Inhalte/Dokumente/DEGAM-S1-Handlungsempfehlung/053-059_%20Klimabewusste%20Verordnung%20von%20Inhalativa/053-059l_S1%20Klimabewusstes%20VO%20Inhalativa_16-05-2022.pdf.
12. 12.↵
    US Department of Health and Human Services, ed. 2020 Focused Updates to the Asthma Management Guidelines: A report from the National Asthma Education and Prevention Program Coordinating Committee Expert Panel Working Group. Published online 2020. Accessed November 8, 2022. Available from: https://www.nhlbi.nih.gov/sites/default/files/publications/AsthmaManagementGuidelinesReport-2-4-21.pdf.
13. 13.↵
    Global Initiative for Chronic Obstructive Lung Disease, ed. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease - 2022 Report. Published online 2022. Accessed November 8, 2022. Available from: https://goldcopd.org/wp-content/uploads/2021/12/GOLD-REPORT-2022-v1.1-22Nov2021_WMV.pdf.
14. 14.↵
    1. Darbà J,
    2. Ramírez G,
    3. Sicras A,
    4. García-Bujalance L,
    5. Torvinen S,
    6. Sánchez-de la Rosa R

    . Identification of factors involved in medication compliance: incorrect inhaler technique of asthma treatment leads to poor compliance. Patient Prefer Adherence 2016;10:135–45.

    OpenUrlPubMed
15. 15.↵
    1. Sanchis J,
    2. Gich I,
    3. Pedersen S

    , Aerosol Drug Management Improvement Team (ADMIT). Systematic Review of Errors in Inhaler Use. Chest 2016;150:394–406.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Kocks JWH,
    2. Chrystyn H,
    3. van der Palen J,
    4. et al

    . Systematic Review of Association between Critical Errors in Inhalation and Health Outcomes in Asthma and COPD. Npj Prim Care Respir Med 2018;28:43.

    OpenUrl
17. 17.↵
    1. Self TH,
    2. Arnold LB,
    3. Czosnowski LM,
    4. Swanson JM,
    5. Swanson H

    . Inadequate Skill of Healthcare Professionals in Using Asthma Inhalation Devices. J Asthma 2007;44:593–8.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Gillette C,
    2. Rockich-Winston N,
    3. Kuhn JA,
    4. Flesher S,
    5. Shepherd M

    . Inhaler Technique in Children With Asthma: A Systematic Review. Acad Pediatr 2016;16:605–15.

    OpenUrlPubMed
19. 19.↵
    1. Mahler DA

    . Peak Inspiratory Flow Rate as a Criterion for Dry Powder Inhaler Use in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc. Published online May 8, 2017:AnnalsATS.201702-156PS.
20. 20.↵
    1. Marlon JR,
    2. Neyens L,
    3. Jefferson M,
    4. Howe P,
    5. Mildenberger M,
    6. Leiserowitz A

    . Yale Climate Opinion Maps 2021. Yale Climate Opinion Maps 2021. Published June 2015. Accessed August 29, 2022. Available from: http://www.nature.com/articles/nclimate2583.